BioFinlandin jäsen

Genomill is a pioneering precision diagnostics company. Company's mission is to democratize the use of liquid biopsies for oncology, infectious disease detection and beyond, by removing the barriers for global access. Our vision is to be a leader in the transformation of precision diagnostics with an ultimate goal of bringing the full potential of liquid biopsies to more people, across the world. Genomill's core technology, Geno1®, is a simple assay-prep workflow enabling fundamental and unprecedented improvements in COGS, performance and scalability – leading to major vertical progress in precision diagnostics.